Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Harbin, Heilongjiang, China Clinical Trials

A listing of Harbin, Heilongjiang, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)

The Purpose of This Study is to Compare the Efficacy, Safety, Immunogenicity and Pharmacokinetics between TQB2303 and Rituximab in Combination With CHOP in Previously Untreated Patients with Diffuse Large B-cell Lymphoma

Phase

0.04 miles

Learn More »

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

The purpose of this study is to see if LY900014 compared to insulin lispro (Humalog), both in combination with insulin glargine or insulin degludec, is safe and effective in participants with type 2 diabetes (T2D).

Phase

6.01 miles

Learn More »

Peripheral Vascular Disease and Coronary Artery Disease

Patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI) and optical coherence tomography (OCT) are included in this study. Two skillful echocardiographers will evaluate peripheral artery plaque characteristics by ultrasound.Ultrasound parameters of peripheral artery will be compared among patients with different coronary culprit lesion characteristics, such as ...

Phase N/A

8.41 miles

Learn More »

Genolimzumab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer

This study is a multicenter, dose-escalating phase Ib clinical study to evaluate the safety and tolerability of GB226 in combination with fruquintinib in the treatment of mCRC, evaluate the pharmacokinetic characteristics of GB226 in combined therapy, evaluate immunogenicity of GB226, and explore the antitumor activity of GB226 in combination with ...

Phase

8.41 miles

Learn More »